Gold nanoparticles-modulated ECL/PEC aptasensor for the dual-mode detection of Alzheimer’s disease biomarker
Microchimica Acta · 2026
DOI: 10.1007/s00604-026-07972-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, 2026. Verfasst von Shuna Zhai und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Shandong Xiehe University, No.6277 Jiqing Road, Jinan, 250109, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Alzheimer Disease, Metal Nanoparticles, Amyloid beta-Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Themen: Demenz
Abstract (Originalsprache)
A dual-mode electrochemiluminescent/photoelectrochemical (ECL/PEC) aptasensor modulated by optical and catalytic properties of gold nanoparticles (Au NPs) is constructed to determine soluble amyloid β oligomer (AβO), a critical Alzheimer’s disease (AD) biomarker. In this system, CdS quantum dots (QDs) are integrated onto an indium tin oxide electrode (ITO), acting as ECL emission source and PEC substrates. The developed sensing system enables signal transduction by exploiting the robust AβO binding ability of the developed aptamer and magnetic isolation as an enrichment strategy. The resultant AβO-dependent T strands can trigger the toehold-mediated strand displacement (TMSD) reaction, consequently enabling the assembly of copious P-Au NPs strands. By the modulation of localized surface plasmon resonance (LSPR) and oxidase-mimic performance of Au NPs on CdS QDs, the boosting ECL signal and quenching PEC response are both observed. Based on the above merits, the aptasensor can successfully determine the AβO level in a linear range spanning from 10 fM to 10 nM, with detection limits as low as 3.1 fM (ECL mode) and 3.3 fM (PEC mode). Furthermore, the applicability of the aptasensor is estimated for AβO detection in real cerebrospinal fluid and serum samples with acceptable signal recoveries, offering a viable, sensitive, and promising approach for the early diagnosis of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing, Shandong Xiehe University, No.6277 Jiqing Road, Jinan, 250109, China.
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, 221116, China. fengqiumei@jsnu.edu.cn.
- Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, 250117, China. jlnn@163.com.
Förderung
- Natural Science Foundation of Jiangsu Province
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Zhai, S., Zhang, P., Shen, C., Wang, R., Tang, J., Feng, Q., & Zhai, J. (2026). Gold nanoparticles-modulated ECL/PEC aptasensor for the dual-mode detection of Alzheimer’s disease biomarker. Microchimica Acta. https://doi.org/10.1007/s00604-026-07972-1
Vancouver
Zhai S, Zhang P, Shen C, Wang R, Tang J, Feng Q, et al. Gold nanoparticles-modulated ECL/PEC aptasensor for the dual-mode detection of Alzheimer’s disease biomarker. Microchimica Acta. 2026. doi:10.1007/s00604-026-07972-1
BibTeX
@article{Zhai2026,
author = {Zhai, Shuna and Zhang, Pei and Shen, Chunhong and Wang, Ruowei and Tang, Jihua and Feng, Qiumei and Zhai, Jiliang},
title = {Gold nanoparticles-modulated ECL/PEC aptasensor for the dual-mode detection of Alzheimer’s disease biomarker},
journal = {Microchimica Acta},
year = {2026},
doi = {10.1007/s00604-026-07972-1}
}
EUVIMED